Social News
Written by: Chen Jiahui
2020-11-26 07:30
Last update date: 2020-11-26 07:30
Chief Executive Carrie Lam Cheng Yuet-ngor postponed the release of his policy address earlier, stating that he would like to seek measures to benefit Hong Kong from the central government, including the central government's agreement with the Hong Kong and Shenzhen governments to build a "Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone", and eight of the buildings are expected to be completed and opened in 2024 .
Earlier, the government also stated that before the completion of the technological innovation cooperation zone, the Hong Kong Science and Technology Park Company would rent part of the Shenzhen Futian Innovation and Technology Park in the form of a "second landlord" and then lease it to a local company.
A government source revealed today (25th) that the two governments are currently discussing the details of supporting facilities and management, including the transportation of biological samples from many biotech companies between the two places.
Government sources said that the "Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone" covers an area of about 1.2 million square meters, about three times the size of the Hong Kong Science Park. There will be 67 buildings, and eight of them are expected to be opened in 2024. The government will submit the funding for the Hong Kong park to the Public Works Panel of the Legislative Council for approval next month.
Before the opening of the cooperation zone, the Hong Kong Science and Technology Park Company will rent a part of the innovation and technology park in Futian, Shenzhen in the form of a "second landlord", and then lease it to a local company to operate under Hong Kong management. The existing building Some refurbishment works may be required, and it is expected that one to two buildings will be opened first in about one to two years.
Biological samples pass the customs or loosen up for transport of samples between settled biological science enterprises
Biomedicine is one of the key scientific research areas in Hong Kong. It is expected that many local biotech companies will also be interested in developing in the Greater Bay Area. However, the current laws in the Mainland prohibit the import and export of biological samples and medical data.
Government sources pointed out that when the two governments are discussing the management and policy support of Shenzhen Futian Innovation and Technology Park, they are expected to include whether to loosen the binding, allowing biotech companies settled in the park to transport biological samples between the two places, and protection of intellectual property rights.
When the two governments are discussing the management and supporting policies of the Shenzhen Futian Innovation and Technology Park, it is expected to include whether biotech companies settled in the park are allowed to transport biological samples between the two places.
(Information Picture/Photo by Lu Yiming)
The Hong Kong Science and Technology Park Company is also responsible for the management of the "Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone" Hong Kong Park and part of the leased area in Shenzhen Futian Science and Technology Park.
Zha Yichao, chairman of the Science and Technology Park Company, said that the government once again strongly supports innovation and technology in the policy address and helps local technology companies seize the opportunities in the Greater Bay Area. He is encouraged by this. Establish partnerships and networks in the district's mainland and overseas markets.
The Science and Technology Park Company also stated that biomedical technology is one of the key points of the Science and Technology Park Company. There are more than 100 biotechnology companies in the park.
The policy address proposes that biotech companies listed in Hong Kong that are not profitable and stocks on the mainland science and technology innovation board will be included in the scope of "Connect" stock selection under certain conditions.
The Science and Technology Park Company stated that it believes that the measures will help promote the atmosphere of venture capital and speed up the research and development process of biotech companies.
▼Eight Key Points of Policy Address 2020▼
+2
+2
+2
2 billion for universities to hire overseas STEM research teams with an average of 20 million per team
As for innovation and technology talents, the policy address recommends that two billion yuan be used to launch the five-year "Outstanding Creative Talents Program" for local UGC-funded universities and employ overseas STEM research teams.
According to government sources, there are a total of 100 places in the plan, and the university as an employer will nominate the approval committee, and the grant will be given as a team unit.
Based on this calculation, each team can receive an average of 20 million yuan in funding.
In fact, the Innovation and Technology Commission has also launched the InnoHK innovative Hong Kong R&D platform in recent years, inviting internationally renowned institutions or commercial units to set up R&D laboratories in Hong Kong.
When asked if there will be overlap between the two, the source pointed out that the "Outstanding Creative Scientists Program" is for more upstream scientific research teams, while InnoHK is for research teams with mid-level projects that have already landed.
Innovative Technology Biotechnology Science Park Hong Kong Science and Technology Park